Methyclothiazide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methyclothiazide and what is the scope of freedom to operate?
Methyclothiazide
is the generic ingredient in five branded drugs marketed by Medpointe Pharm Hlc, Abbvie, Chartwell Rx, Ivax Pharms, Mylan, Mylan Pharms Inc, Par Pharm, Usl Pharma, Watson Labs, and Abbott, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for methyclothiazide.
Summary for methyclothiazide
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 10 |
NDAs: | 17 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 6,952 |
DailyMed Link: | methyclothiazide at DailyMed |
Medical Subject Heading (MeSH) Categories for methyclothiazide
US Patents and Regulatory Information for methyclothiazide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ivax Pharms | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 087913-001 | Jun 3, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | ENDURON | methyclothiazide | TABLET;ORAL | 012524-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | ENDURON | methyclothiazide | TABLET;ORAL | 012524-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Rx | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089837-001 | Aug 18, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | DIUTENSEN-R | methyclothiazide; reserpine | TABLET;ORAL | 012708-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |